CliffBio
small molecule

FLURAZEPAM HYDROCHLORIDE

FLURAZEPAM HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLURAZEPAM HYDROCHLORIDE
Active ingredientFLURAZEPAM HYDROCHLORIDE
Strength15MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1986
Marketing statusDISCN

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.